Trial Profile
Evaluation of additive effects of zileuton to Advair [fluticasone/salmeterol] on total exhaled, bronchial, and alveolar nitric oxide in asthmatics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Zileuton (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- 15 Jan 2008 New trial record.